Decreased Antimicrobial Resistance Gene Richness Following Fecal Microbiota, Live-jslm (REBYOTA®) Administration: Post Hoc Analysis of PUNCH CD3 - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Reduced Diversity of Antimicrobial Resistance Genes After Administration of Fecal Microbiota, Live-jslm (REBYOTA®): A Post Hoc Evaluation of PUNCH CD3

  • By

  • Elizabeth Adamowicz

  • Colleen S Kraft

  • Tonya Ward

  • Nirja Mehta

  • William D Shannon

  • Rohan Mishra

  • Ken F Blount

  • July 2, 2025

Share

Original Source(s)

Decreased Antimicrobial Resistance Gene Richness Following Fecal Microbiota, Live-jslm (REBYOTA®) Administration: Post Hoc Analysis of PUNCH CD3

  • by Elizabeth Adamowicz, Colleen S Kraft, Tonya Ward, Nirja Mehta, William D Shannon, Rohan Mishra, Ken F Blount

  • July 2, 2025

Related Content

Immune dysregulation drives the relapse of peritoneal dialysis-associated peritonitis: a single-center prospective study

Correction: Incidence of Clostridium difficile infection and enteric pathogens in children with inflammatory bowel disease presenting with disease exacerbation

Vaginal dysbiosis and inflammatory signatures in preterm labor: an integrated model for predicting preterm birth